After a tough third quarter in which Emergent BioSolutions cut more than $100 million from its revenue guidance, the company is gaining some much-needed cash with an asset sale to Bavarian Nordic.

Emergent was “an obscure contractor in an obscure corner of the federal bureaucracy,” according to reporters at the New York Times who began looking into its operations as Covid unfolded, “applying ...

A failed government-arranged marriage between ill-suited partners has devolved into one last contract squabble. Monday, Emergent BioSolutions, which made high-profile errors in the production of two ...

SPRINGFIELD, OR / ACCESS Newswire / October 28, 2025 / Emergent has announced the official deployment of its NERIS-compliant Record Management System (RMS) update, enabling public safety departments ...

AI became powerful because of interacting mechanisms: neural networks, backpropagation and reinforcement learning, attention, ...

Inspection reports obtained by ABC News show a series of quality control issues. Even as shots of the Johnson & Johnson COVID-19 vaccine resume across the country following a recent ...

Emergent, an AI-powered software creation platform that allows users to build full-stack web and mobile applications with minimal coding, has raised $70 million in a Series B funding round led by Khos ...

With advanced AI tech reshaping the world before our very eyes, it can be troubling to realize even the creators of these systems don't fully understand how they work. One example of this is AI ...

When contract-manufacturer Emergent BioSolutions contaminated at least 15 million doses of Johnson & Johnson’s COVID-19 vaccine and millions more doses of AstraZeneca’s vaccine at its Baltimore ...